Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Orthopaedic Surgery Outcomes
Orthopaedic Surgery ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 570 participating sites.
| Orthopaedic Surgery (570 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 678 | 0.29% | 0.26% |
| 30 Day Morbidity | 678 | 2.51% | 4.07% |
| Cardiac | 678 | 0.44% | 0.41% |
| Pneumonia | 678 | 0.29% | 0.35% |
| Unplanned Intubation | 678 | 0.15% | 0.22% |
| Ventilator > 48 Hours | 678 | 0.00% | 0.09% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 678 | 1.62% | 0.88% |
| Renal Failure | 677 | 0.59% | 0.41% |
| Urinary Tract Infection (UTI) | 678 | 0.29% | 0.65% |
| Surgical Site Infection (SSI) | 678 | 1.03% | 1.70% |
| Sepsis | 678 | 0.00% | 0.49% |
| C.diff Colitis | 678 | 0.15% | 0.09% |
| Unplanned Reoperation | 678 | 1.18% | 2.09% |
| Unplanned Readmission | 678 | 5.16% | 4.69% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
